ClinVar Miner

Submissions for variant NM_170707.4(LMNA):c.1478A>C (p.Gln493Pro)

dbSNP: rs1553266048
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000594075 SCV000701771 uncertain significance not provided 2016-09-30 criteria provided, single submitter clinical testing
Invitae RCV001867919 SCV002184933 pathogenic Charcot-Marie-Tooth disease type 2 2022-11-29 criteria provided, single submitter clinical testing This missense change has been observed in individual(s) with clinical features of autosomal dominant LMNA-related muscular dystrophy (PMID: 29893365, 32571898; Invitae). In at least one individual the variant was observed to be de novo. For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LMNA protein function. ClinVar contains an entry for this variant (Variation ID: 497324). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 493 of the LMNA protein (p.Gln493Pro).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.